Transcriptome-based assessment of immune infiltration for molecular selection of pediatric patients with solid tumors for combination immune checkpoint inhibitor therapy

被引：0
|
作者：
Shen, Yaoqing
Mayoh, Chelsea
Nabbi, Arash
Santiago, Raoul
Bianco, Stephanie
Bancarz, Iain R.
Williamson, Laura
Corbett, Richard
Krekhno, Zakhar
Davidson, Scott
Fortuna, Alexander
Yuki, Kyoko E.
Connolly, Denise
Morgenstern, Daniel
Ekert, Paul G.
Shlien, Adam
Jones, Steven J. M.
Deyell, Rebecca J.
Cohen-Gogo, Sarah
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 17期
关键词：
D O I：
10.1158/1538-7445.PEDIATRIC24-B015
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B015
引用
收藏
页数：4
相关论文
共 50 条
  • [11] Immune Checkpoint Inhibitors in Pediatric Solid Tumors: Status in 2018
    Kabir, Tanvir F.
    Chauhan, Aman
    Anthony, Lowell
    Hildebrandt, Gerhard C.
    OCHSNER JOURNAL, 2018, 18 (04): : 370 - 376
  • [12] Immune Checkpoint Inhibitor-Based Combination Therapy for Colorectal Cancer: An Overview
    Li, Jingjing
    Xu, Xuanfu
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2023, 16 : 1527 - 1540
  • [13] Marker-guided immune checkpoint inhibitor-based combination therapy
    Hung, Mien-Chie
    CANCER SCIENCE, 2022, 113 : 1248 - 1248
  • [14] Molecular imaging biomarkers for immune checkpoint inhibitor therapy
    van de Donk, Pim P.
    de Ruijter, Laura Kist
    Lub-de Hooge, Marjolijn N.
    Brouwers, Adrienne H.
    van der Wekken, Anthonie J.
    Oosting, Sjoukje F.
    Fehrmann, Rudolf S. N.
    de Groot, Derk Jan A.
    de Vries, Elisabeth G. E.
    THERANOSTICS, 2020, 10 (04): : 1708 - 1718
  • [15] Comparison of the Impact of Immune-Related Adverse Events Due to Immune Checkpoint Inhibitor Dual Combination Therapy and Immune Checkpoint Inhibitor Plus Tyrosine Kinase Inhibitor Combination Therapy in Patients with Advanced Renal Cell Carcinoma
    Ishihara, Hiroki
    Nemoto, Yuki
    Nakamura, Kazutaka
    Tachibana, Hidekazu
    Fukuda, Hironori
    Yoshida, Kazuhiko
    Kobayashi, Hirohito
    Iizuka, Junpei
    Shimmura, Hiroaki
    Hashimoto, Yasunobu
    Kondo, Tsunenori
    Takagi, Toshio
    TARGETED ONCOLOGY, 2023, 18 (01) : 159 - 168
  • [16] The inflammatory tumor microenvironment in patients with solid tumors with brain metastases after progression to immune checkpoint inhibitor therapy
    Starzer, A. M.
    Kleinberger, M.
    Feldmann, K.
    Tomasich, E.
    Hatziioannou, T.
    Paiato, C.
    Heller, G.
    Kreminger, J.
    Traint, S.
    Steindl, A.
    Ressler, J. M.
    Widhalm, G.
    Gatterbauer, B.
    Dieckmann, K.
    Muellauer, L.
    Preusser, M.
    Berghoff, A. S.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 272 - 272
  • [17] Comparison of the Impact of Immune-Related Adverse Events Due to Immune Checkpoint Inhibitor Dual Combination Therapy and Immune Checkpoint Inhibitor Plus Tyrosine Kinase Inhibitor Combination Therapy in Patients with Advanced Renal Cell Carcinoma
    Hiroki Ishihara
    Yuki Nemoto
    Kazutaka Nakamura
    Hidekazu Tachibana
    Hironori Fukuda
    Kazuhiko Yoshida
    Hirohito Kobayashi
    Junpei Iizuka
    Hiroaki Shimmura
    Yasunobu Hashimoto
    Tsunenori Kondo
    Toshio Takagi
    Targeted Oncology, 2023, 18 : 159 - 168
  • [18] Subclinical Myocarditis After Combination Immune Checkpoint Inhibitor Therapy
    Giblin, Gerard T.
    Dennehy, Colum
    Featherstone, Hannah
    Clarke, Rachel
    Murphy, Laura
    Timlin, Deirdre
    O'Keane, Conor
    Mulligan, Niall
    Kelly, Catherine M.
    Joyce, Emer
    CIRCULATION-HEART FAILURE, 2021, 14 (02) : E007524
  • [19] Risk Factors for Emergency Room and Hospital Care Among Patients With Solid Tumors on Immune Checkpoint Inhibitor Therapy
    Parikh, Anish B.
    Zhong, Xiaobo
    Mellgard, George
    Qin, Qian
    Patel, Vaibhav G.
    Wang, Bo
    Alerasool, Parissa
    Garcia, Philip
    Leiter, Amanda
    Gallagher, Emily J.
    Clinton, Steven
    Mortazavi, Amir
    Monk, Paul
    Folefac, Edmund
    Yin, Ming
    Yang, Yuanquan
    Galsky, Matthew
    Oh, William K.
    Tsao, Che-Kai
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2021, 44 (03): : 114 - 120
  • [20] COM701 (A NOVEL IMMUNE CHECKPOINT INHIBITOR) IN PATIENTS WITH ADVANCED SOLID TUMORS
    Elnaggar, A.
    Luke, J.
    Hamilton, E.
    Chmielowski, B.
    Ileana-Dumbrava, E.
    Patnaik, A.
    Lim, E.
    Adewoye, A.
    Hunter, J.
    Olweny, J.
    Sharma, M.
    Sullivan, R.
    Vaena, D.
    Rasco, D.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A161 - A161
12345